Difficulty: Medium
Average Score: 94%
Practice
A nurse is caring for a client who is about to begin taking folic acid to treat megaloblastic anemia. The nurse should monitor which of the following laboratory values to determine therapeutic effectiveness?
Correct answer
B
Rationale
The correct answer is B: Reticulocyte count. Reticulocytes are immature red blood cells. In megaloblastic anemia, there is a decrease in red blood cell production due to a deficiency in folic acid. Monitoring reticulocyte count helps determine if the folic acid treatment is increasing red blood cell production.
A: Amylase level is not relevant to monitoring the effectiveness of folic acid in treating megaloblastic anemia.
C: C-reactive protein is a marker for inflammation and not specific to monitoring anemia treatment.
D: Creatinine clearance is used to assess kidney function, not the effectiveness of folic acid in treating anemia.
A: Amylase level is not relevant to monitoring the effectiveness of folic acid in treating megaloblastic anemia.
C: C-reactive protein is a marker for inflammation and not specific to monitoring anemia treatment.
D: Creatinine clearance is used to assess kidney function, not the effectiveness of folic acid in treating anemia.